1YBottom 25% of the group
Rank 48 of 63 funds
Return +17.28%
1Y returns of 63 funds in the Health Care group, sorted from highest to lowest. This fund ranks 48No. 1 is SCBGENOME(E) +68.99%
Krungsri Global Healthcare Equity RMF
Shows where this fund stands in its group. Not investment advice · Data as of 4 Nov 2026
KFHCARERMF invests through the master fund JPMorgan Funds - Global Healthcare Fund 99.31%
This fundKFHCARERMF
The fund that actually investsJPMorgan Funds - Global Healthcare FundThis fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
Eli Lilly and Co LLY7.94%
ABBVIE ABBV7.25%Data as of 30 Sep 2026 · Top 6 shown, the rest grouped as Other · per JPMorgan fact sheet
Over the past year it trailed half its group; over 5 years it returned −0.24% per year (Better than half the group)
No. 1 is SCBGENOME(E) +68.99%
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 4 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +9.98% | +3.37% | +5.10% | +11.75% | +9.29% | +17.95% | +17.28% | +24.99% | −1.22% | +50.03% | +72.11% |
Largest drawdown in the selected period −26.30% Previous peak 5 Aug 2015 (NAV 12.4883) → Trough 4 Nov 2016 (NAV 9.2040) · Back to the previous peak on 18 Feb 2020, after 3 years 3 months
Currently −1.22% from the peak NAV of 16.0364 (4 Nov 2021)
Over 5 years, KFHCARERMF returned -0.02 per unit of volatility, ranking 17 of 33 funds · The highest is FP HCARE-A (0.44)
กองทุนจะลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศที่มีเป้าหมายให้ผลตอบแทนในการถือครองหน่วยลงทุนในระยะยาว โดยจะลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศ ชื่อ JPMorgan Funds - Global Healthcare Fund, Class: JPM Global Healthcare C (acc) - USD (“กองทุนหลัก”) ซึ่งเป็นกองทุนรวมที่เสนอขายให้กับผู้ลงทุนทั่วไป… Its largest holdings are Eli Lilly 7.80% · AbbVie 6.90% · Johnson & Johnson 6.10% (fact sheet 30 Sep 2026)
Risk level 7 of 8 (High risk). Since 27 Nov 2014, its NAV has fallen as much as −26.30% from its peak.
Actual total expense ratio (TER) 1.54% a year, against a ceiling of 4.65%. Management fee 1.34%. Front-end fee 0.00%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 500 THB, subsequent purchases 500 THB. Buy orders accepted until 15:30, sell orders until 14:30, and redemption proceeds are paid T+4
KFHCARERMF is a retirement mutual fund (RMF). You can buy up to 30% of your assessable income, capped at 500,000 THB a year together with other retirement funds. You must hold it for at least 5 years and can sell only once you turn 55. Check the latest conditions with the Revenue Department before investing
Hedged at the manager's discretion. As of 30 Sep 2026, 90.25% of the value of its foreign investments was hedged
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Merck & MRK5.26%
Thermo Fisher TMO4.57%
Novartis NOVN4.47%
AstraZeneca AZN.L4.07%
Unitedhealth Group UNH3.28%
Abbott Laboratories ABT2.88%
Danaher DHR2.88%Eli Lilly and Co LLYDiabetes and weight-loss drugs
ABBVIE ABBVHospitals, medicines and medical equipment
An American medicines and medical devices company, with products such as cancer drugs and surgical instruments
Merck & MRKHospitals, medicines and medical equipment
Thermo Fisher TMOAn American company selling scientific instruments, reagents and services for laboratories
Novartis NOVNHospitals, medicines and medical equipment
AstraZeneca AZN.LHospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Danaher DHRHospitals, medicines and medical equipment
Based on the master fund's share of this fund's value (99.31% as of 30 Sep 2026) × each stock's weight in the master fund · stocks as of 30 Sep 2026 · fact sheet from JPMorgan · Illustrations are for explanation only, not individual stock recommendations
No. 1 is SCBGENOME(E) +22.37% per year
No. 1 is FP HCARE-A +6.71% per year
| +58.41% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.0 | +0.2 | −6.3 | −0.7 | +2.3 | +6.1 | −0.9 | +2.7 | −2.3 | +8.2 | +1.0 | · | +10.0* |
| 2025 | +7.9 | −1.3 | −3.3 | −2.8 | −4.4 | +1.7 | −0.7 | +2.3 | +0.3 | +5.3 | +7.5 | −1.5 | +10.6 |
| 2024 | +1.9 | +2.9 | +1.8 | −3.9 | +0.4 | +2.7 | +1.7 | +4.5 | −4.6 | −4.2 | −1.2 | −7.6 | −6.2 |
| 2023 | −0.9 | −2.5 | +1.3 | +1.5 | −4.3 | +3.7 | +0.7 | −0.5 | −5.0 | −7.3 | +5.7 | +7.1 | −1.5 |
| 2022 | −10.0 | +0.9 | +7.7 | −6.7 | −2.5 | −1.7 | +4.4 | −3.0 | −3.0 | +3.8 | +1.4 | −1.2 | −10.6 |
